FDA Launches Crackdown on Deceptive Drug Advertising
The U.S. Department of Health and Human Services (DHHS) and the Food and Drug Administration (FDA) announced on 09 SEP 2025 sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements. The FDA sent thousands of letters warning pharmaceutical companies to remove misleading ads and issuing approximately 100 cease-and-desist letters to companies with deceptive ads.